Show Notes
Season finale alert! 🚨
We're diving into a cutting-edge breakthrough in gut health: Fecal Microbiota transplants (FMT) with an innovative new product soon hitting the market.
Host Ariadna Masó (SANNO founder & CEO) speaks with Patricia del Rio, Director of Business Development at Mikrobiomik, a pioneering biopharma company focused on microbiome-based therapies.
Patricia shares the science behind their FMT capsules, tackling antibiotic resistance and revolutionizing patient care.
Tune in to learn about:
The fascinating world of the fecal microbiome 🦠
How FMTs are reshaping treatment for Clostridioides difficile.
Challenges and promises of microbiome-based therapies 🚀
Get ready to discover how innovation is changing the future of gut health! 🎙️
#GutHealth #Microbiome #FecalMicrobiotaTransplant #HealthInnovation #ClinicalTrials #Healthcare #MicrobiomeTherapies #Podcast #PatientCare #FutureOfMedicine
More from SANNO Health
Aging accelerates during perimenopause - and most women are never told that, or that the transition can last up to ten years.
🎙️ Menopause is not a disease: it's a whole-body recalibration. And yet, so many women are still not getting the full picture.
Is your brain health being affected by hidden inflammation? In this episode, we explore the powerful connection between neuroinflammation, gut health, and the lifestyle choices that may influence your cognitive well-being.
Worried about LDL cholesterol and heart disease risk? In this episode, we unpack what cholesterol can (and can’t) tell you and why inflammation and the right assessments may matter more than a single lab value.
Fertility isn’t isolated gut health, insulin resistance, and chronic stress can all influence hormones, cycle regularity, and reproductive health. In this episode, we explore what an evidence-based, functional approach to fertility care can look like.